Results 191 to 200 of about 47,712 (207)

Treatment with GLP-1 Receptor Agonists

2018
Madsbad, Sten, Holst, Jens J.
openaire   +2 more sources

GLP-1 receptor agonists for type 2 diabetes

The Lancet, 2009
de Block, Christophe, Van Gaal, Luc
openaire   +3 more sources

Rationale Use of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes

Current Diabetes Reports, 2013
Jeff Unger
exaly  

GLP-1 receptor agonists in clinical practice

Medicina Clínica (English Edition)
openaire   +2 more sources

The promise and hope of GLP-1 receptor agonists

The Lancet Diabetes & Endocrinology
Priya, Sumithran, Jamy, Ard
openaire   +2 more sources

Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative Disorders: A Large-Scale Propensity-Matched cohort study

International Immunopharmacology
Nabeela Siddeeque, Mohammad H Hussein, Ahmed Abdelmaksoud   +2 more
exaly  

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiac Disorders

Annals of Pharmacotherapy, 2016
Nancy Toedter Williams
exaly  

A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes

Expert Opinion on Pharmacotherapy, 2012
Eduard Montanya
exaly  

The GLP-1 Receptor Agonist Revolution

JACC
Stephen J. Nicholls, Adam J. Nelson
openaire   +1 more source

Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events

Frontiers in Pharmacology
Jiahao Li, Xiaoyan Zhong
exaly